478
Participants
Start Date
May 31, 2013
Primary Completion Date
January 31, 2025
Study Completion Date
July 31, 2027
XELOX regimen according to standard procedures
FOLFOX regimen according to standard procedures
Surgery
radiofrequency ablation (RFA)
transarterial chemo-embolization using irinotecan drug-eluted beads ((DEBIRI-)TACE)
stereotactic body radiation therapy (SBRT)
Bevacizumab
may be added to both regimens according to standard procedures
tumor biopsy
at baseline (diagnostic or study) biopsy and after 3 or 4 cycles an optional tumor biopsy
Jeroen Bosch Ziekenhuis, 's-Hertogenbosch
Noordwest Ziekenhuis Groep, Alkmaar
Ziekenhuisgroep Twente, Almelo
Meander Medisch Centrum, Amersfoort
Amstelveen Ziekenhuis, Amstelveen
Antoni van Leeuwenhoek, Amsterdam
Gelre, Apeldoorn
Amphia Ziekenhuis, Breda
Deventer Ziekenhuis, Deventer
Albert Schweizer ziekenhuis, Dordrecht
Maxima Medisch Centrum, Eindhoven
Medisch Spectrum Twente, Enschede
Admiraal de Ruyter Hospital, Flushing
Dijklander, Hoorn
Medisch Centrum Leeuwarden, Leeuwarden
Sint Antonius Ziekenhuis, Nieuwegein
Radboud University Medical Center, Nijmegen
Bravis ziekenhuis, Roosendaal
Franciscus Gasthuis, Rotterdam
IJsselland ziekenhuis, Rotterdam
Maasstadziekenhuis, Rotterdam
Medisch Centrum Haaglanden, The Hague
Elisabeth Tweesteden Ziekenhuis, Tilburg
Zaans Medisch Centrum, Zaandam
Isala Klinieken, Zwolle
University College London Hospital, London
University Hospital Southampton, Southampton
VU Medical Center, Amsterdam
Erasmus University Medical Center, Rotterdam
Collaborators (1)
Erasmus Medical Center
OTHER
Radboud University Medical Center
OTHER